Dear Colleagues,

We have the great pleasure to invite you to join us for the 19th European Association of Dermato-Oncology (EADO) Congress taking place as a on-site meeting with additional virtual access from April 20–22, 2023 in the amazing city of Rome, Italy. The conference provides updated scientific and clinical achievements in a wide spectrum of skin tumors including melanoma, keratinocyte carcinomas and rare malignant neoplasms.

Over 1,000 participants from Europe and around the world are expected to attend. The EADO Congress is the largest conference in dermato-oncology, there are no competing meetings in this field. The world´s leading experts have been invited as speakers and will offer you the opportunity to gain a comprehensive insight into all areas of dermato-oncology.

Rome, also known as The Eternal City, is one of the most attractive cities in the world and well connected by many airlines. The city offers a wealth of historical sites as well as impressive architecture with countless charming squares and fountains. The historic center is a UNESCO World Heritage Site. Important attractions such as the Colosseum, the independent Vatican State as well as the Altar of the Fatherland are world-renowned.

Looking forward to welcoming you online or in Rome in April 2023!

Prof. Dr. Ketty Peris

Rome, Italy
Congress President

Prof. Dr. Claus Garbe

Tuebingen, Germany
Congress President

Congress Destination

An historic world heritage city, Rome is rich in architecture and art. The challenge when visiting the city is most probably to decide what not to do.

More

Registration

Don't miss the change and book your ticket now! Participation in the congress is possible on-site or virtually and includes access to the on-demand area.

More

Program

The final program for the onsite meeting with additional virtual access is available here for download.

Download

Call for Abstracts

Abstract submission deadline is March 1, 2023.

More

Subscribe to our newsletter

Subscribe to our newsletter to receive the latest news on the congress! You can unsubscribe from the mailing list at any time.

Subscribe to newsletter